📊 POSC Key Takeaways
Is Positron Corp. (POSC) a Good Investment?
POSITRON CORP is in acute financial distress with severe operational losses (-$10.6M on $461.5K revenue), negative gross margins (-458.2%), and critical cash burn ($4.7M annually) that leaves less than 6 months of runway at current burn rate. The company exhibits fundamental business model failure with no visible path to profitability, deteriorating trends (-345.7% YoY net income decline), and insufficient revenue generation to support operations.
Why Buy Positron Corp. Stock? POSC Key Strengths
- Low financial leverage (Debt/Equity 0.11x) limits bankruptcy risk from creditors
- Adequate short-term liquidity ratios (Current 1.39x, Quick 1.11x) provide near-term operating capacity
- Minimal debt obligations ($153.7K) reduce fixed interest burden
POSC Stock Risks: Positron Corp. Investment Risks
- Critical cash runway: $2.5M cash with $4.7M annual operating burn rate implies insolvency within 6-12 months without revenue transformation
- Negative gross margin (-458.2%) indicates fundamental business model failure; losing money on every dollar of sales
- Negligible and stagnant revenue ($461.5K, 0% growth) insufficient to support $4.0M asset base and operational costs; deteriorating losses suggest accelerating decline
Key Metrics to Watch
- Monthly cash burn rate and remaining runway (survival threshold metric)
- Revenue growth and gross margin trajectory (path to viability assessment)
- Operating cash flow trend (whether losses are stabilizing or accelerating)
Positron Corp. (POSC) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Positron Corp. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
POSC Profit Margin, ROE & Profitability Analysis
POSC vs Healthcare Sector: How Positron Corp. Compares
How Positron Corp. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Positron Corp. Stock Overvalued? POSC Valuation Analysis 2026
Based on fundamental analysis, Positron Corp. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Positron Corp. Balance Sheet: POSC Debt, Cash & Liquidity
POSC Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Positron Corp.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-0.09 indicates the company is currently unprofitable.
POSC Revenue Growth, EPS Growth & YoY Performance
POSC Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2015 | $304.0K | -$255.0K | N/A |
| Q2 2015 | $328.0K | -$201.0K | N/A |
| Q1 2015 | $346.0K | -$554.0K | N/A |
| Q3 2014 | $351.0K | -$1.4M | N/A |
| Q2 2014 | $355.0K | -$201.0K | N/A |
| Q1 2014 | $371.0K | -$861.0K | N/A |
| Q2 2013 | $432.0K | -$1.1M | N/A |
| Q1 2013 | $371.0K | -$1.2M | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Positron Corp. Dividends, Buybacks & Capital Allocation
POSC SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Positron Corp. (CIK: 0000844985)
📋 Recent SEC Filings
❓ Frequently Asked Questions about POSC
What is the AI rating for POSC?
Positron Corp. (POSC) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are POSC's key strengths?
Claude: Low financial leverage (Debt/Equity 0.11x) limits bankruptcy risk from creditors. Adequate short-term liquidity ratios (Current 1.39x, Quick 1.11x) provide near-term operating capacity.
What are the risks of investing in POSC?
Claude: Critical cash runway: $2.5M cash with $4.7M annual operating burn rate implies insolvency within 6-12 months without revenue transformation. Negative gross margin (-458.2%) indicates fundamental business model failure; losing money on every dollar of sales.
What is POSC's revenue and growth?
Positron Corp. reported revenue of $461.5K.
Does POSC pay dividends?
Positron Corp. does not currently pay dividends.
Where can I find POSC SEC filings?
Official SEC filings for Positron Corp. (CIK: 0000844985) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is POSC's EPS?
Positron Corp. has a diluted EPS of $-0.34.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is POSC a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Positron Corp. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is POSC stock overvalued or undervalued?
Valuation metrics for POSC: ROE of -734.4% (sector avg: 15%), net margin of -2,297.8% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy POSC stock in 2026?
Our dual AI analysis gives Positron Corp. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is POSC's free cash flow?
Positron Corp.'s operating cash flow is $-4.7M, with capital expenditures of $0.0. FCF margin is -1,018.6%.
How does POSC compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -2,297.8% (avg: 12%), ROE -734.4% (avg: 15%), current ratio 1.39 (avg: 2).